Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
05/10/2012 | US20120114556 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
05/10/2012 | CA2854619A1 Methods for producing virus particles with simplified glycosylation of surface proteins |
05/10/2012 | CA2854437A1 Peptide compositions that downregulate tlr-4 signaling pathway and methods of producing and using same |
05/10/2012 | CA2818080A1 Densovirus-derived vector for gene transfer in insects |
05/10/2012 | CA2816913A1 Novel antigen of enterococcal pathogens and use thereof as vaccine component for therapy and/or prophylaxis |
05/10/2012 | CA2816796A1 Preparation of neutralizing antibody to human herpesvirus 6 glycoprotein q1 and analysis thereof |
05/10/2012 | CA2816584A1 Compositions of a peptide-based system for cell-specific targeting |
05/10/2012 | CA2816575A1 A new variant of antihemophilic factor viii having increased specific activity |
05/10/2012 | CA2816529A1 Immune-modulating agents and uses therefor |
05/10/2012 | CA2816236A1 Stress-resistant plants and their production |
05/10/2012 | CA2815967A1 Anti-diabetic compounds |
05/10/2012 | CA2815887A1 Plant expression system |
05/10/2012 | CA2815727A1 Modulation of immune responses by the poxviral k4 protein |
05/10/2012 | CA2814704A1 Methods and vectors for cell immortalisation |
05/09/2012 | EP2450707A1 Lung tissue model |
05/09/2012 | EP2450446A2 Increasing levels of nicotinic alkaloids |
05/09/2012 | EP2450445A1 Mutant G-protein coupled receptor with increased conformational stability |
05/09/2012 | EP2450437A2 Gene defects and mutant ALK kinase in human solid tumors |
05/09/2012 | EP2450374A1 Peptide and use thereof |
05/09/2012 | EP2450373A2 Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
05/09/2012 | EP2450372A1 Regulatory t cell epitopes, compositions and uses thereof |
05/09/2012 | EP2450371A1 Regulatory t cell epitopes, compositions and uses thereof |
05/09/2012 | EP2450370A1 Regulatory t cell epitopes, compositions and uses thereof |
05/09/2012 | EP2450369A1 Regulatory t cell epitopes, compositions and uses thereof |
05/09/2012 | EP2450368A1 Regulatory t cell epitopes, compositions and uses thereof |
05/09/2012 | EP2450367A1 Regulatory t cell epitopes, compositions and uses thereof |
05/09/2012 | EP2450366A1 Regulatory t cell epitopes, compositions and uses thereof |
05/09/2012 | EP2450365A1 T-cell death-inducing epitopes |
05/09/2012 | EP2450364A1 Process for production of peptide thioester |
05/09/2012 | EP2450053A1 Novel antigen of enterococcal pathogens and use thereof as vaccine component for therapy and/or prophylaxis |
05/09/2012 | EP2450050A1 IL-17A/F heterodimeric polypeptides and therapeutic uses thereof |
05/09/2012 | EP2449378A1 Method for the detection of organ or tissue injury |
05/09/2012 | EP2449111A2 Expression of transcription regulators that provide heat tolerance |
05/09/2012 | EP2449105A2 Use of interfering rna for treating an hiv infection |
05/09/2012 | EP2449103A2 Isolation of unknown rearranged t-cell receptors from single cells |
05/09/2012 | EP2449101A1 Neurotoxins exhibiting shortened biological activity |
05/09/2012 | EP2449096A1 A method of preparation of a biological particulate structure |
05/09/2012 | EP2448971A1 Methods for treatment of muscular dystrophy |
05/09/2012 | EP2448968A1 N-terminal truncated amyloid beta protofibrils/ oligomers for use in therapeutic and diagnostic methods for alzheimer's disease |
05/09/2012 | EP2448965A1 Multimeric peptide conjugates and uses thereof |
05/09/2012 | EP2448964A1 Extracellular allosteric inhibitor binding domain from a tyrosine kinase receptor |
05/09/2012 | EP2448963A1 T cell receptors |
05/09/2012 | EP2448962A1 Insulin derivatives |
05/09/2012 | EP2448961A2 Targets for retrovirus associated diseases |
05/09/2012 | EP2448960A1 Markers of xmrv infection and uses thereof |
05/09/2012 | EP2448959A1 Hyr1 as a target for active and passive immunization against candida |
05/09/2012 | EP2448958A1 Human milk peptides |
05/09/2012 | EP2448957A2 Methods and compositions for affecting the differentiation of clostridia in culture |
05/09/2012 | EP2448598A1 Swine influenza hemagglutinin variants |
05/09/2012 | EP2448596A2 Compositions and methods for diagnosing and/or treating influenza infection |
05/09/2012 | EP2448592A1 Vaccines and compositions against streptococcus pneumoniae |
05/09/2012 | EP2297195B9 Antibacterial peptides |
05/09/2012 | EP2267024B1 Production of recombinant Il-18 binding protein |
05/09/2012 | EP1979375B9 Lantibiotic biosynthetic gene clusters from a. garbadinensis and a. liguriae |
05/09/2012 | EP1766021B1 Polynucleotides for the detection of escherichia coli o157:h7 and escherichia coli o157:nm verotoxin producers |
05/09/2012 | EP1737966B1 Cancer specific promoters |
05/09/2012 | EP1711052B1 Mouse model for psoriasis and psoriatic arthritis |
05/09/2012 | EP1660686B1 Hpv cd8+ t-cell epitopes |
05/09/2012 | EP1498027B1 Plant with improved organogenesis and method of constructing the same |
05/09/2012 | EP1492813B1 OX40R binding agents |
05/09/2012 | EP1444356B1 Identifying epitopes and reducing the allergenicity of food proteins |
05/09/2012 | EP1427830B1 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY |
05/09/2012 | EP1399181B1 Peptide vaccines against group a streptococci |
05/09/2012 | EP1368064B1 Synthesis of tetradentate peptide-chelate conjugates for colorectal cancer diagnosis |
05/09/2012 | CN1902219B Plants having modified growth characteristics and a method for making the same |
05/09/2012 | CN1367833B Streptococcus pneumoniae proteins and nucleic acid molecules |
05/09/2012 | CN102449483A Method for detecting antibody against sith-1 in biological sample |
05/09/2012 | CN102449147A Method for highly sensitive detection of protein-protein interaction |
05/09/2012 | CN102449140A Methods of inhibiting photoreceptor apoptosis |
05/09/2012 | CN102448989A Anti-cd40 antibodies and uses thereof |
05/09/2012 | CN102448984A Compositions and methods for using multispecific-binding proteins comprising an antibody-receptor combination |
05/09/2012 | CN102448983A Fibromodulin peptide |
05/09/2012 | CN102448982A Compositions and methods for modulating the activity of complement regulatory proteins on target cells |
05/09/2012 | CN102448981A Methylglyoxal-scavenging compounds and their use for the prevention and treatment of pain and/or hyperalgesia |
05/09/2012 | CN102448980A C6orf167 peptides and vaccines containing the same |
05/09/2012 | CN102448979A Method for purifying recombinant FSH |
05/09/2012 | CN102448501A Methods and compositions for the treatment of cirrhosis and liver fibrosis |
05/09/2012 | CN102448489A Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use |
05/09/2012 | CN102443600A Preparation method of recombinant soluble hSHH-N protein |
05/09/2012 | CN102443593A Preparation method for beta-lactamase inhibitory polypeptide and expression vector used therein |
05/09/2012 | CN102443586A Protein for treating tumor |
05/09/2012 | CN102443548A Method for producing gamma-carboxylated proteins |
05/09/2012 | CN102443062A Human brain tissue specific gene LRRC4 monoclonal antibody, its preparation and application method |
05/09/2012 | CN102443058A Suppression of B-cell apoptosis in transgenic animals expressing humanized immunoglobulin |
05/09/2012 | CN102443057A Recombinant humanized collagen and its preparation method |
05/09/2012 | CN102443056A Exon deleted variant of epidermal growth factor receptor |
05/09/2012 | CN102443055A Process for purifying recombinant human tumor necrosis factor related apoptosis inducing ligand |
05/09/2012 | CN102443054A Alpha-TTP gene in sheep, cloning method and encoded proteins thereof |
05/09/2012 | CN102443053A Application of using streptococcus suis type-2 hy0245 gene encoded proteins as protective antigens |
05/09/2012 | CN102443052A Peptide of HIV for adjusting or aiding protein, compositions and the application thereof |
05/09/2012 | CN102443051A Recombinant antigen protein for detecting chikungunya virus, kit and application thereof |
05/09/2012 | CN102441174A DNA vaccines against hantavirus infections |
05/09/2012 | CN101928710B Anticoagulation molecule Rhipilin-1 gene sequence of Rhipicephalus haemaphysaloides, recombinant expression and application |
05/09/2012 | CN101891807B Canola protein isolate compositions |
05/09/2012 | CN101870976B Gene synthesis duck alpha interferon gene and protein expression |
05/09/2012 | CN101538323B Method for purifying Exenatide |
05/09/2012 | CN101531710B RF1 antigen, preparation method and application thereof |
05/09/2012 | CN101514229B Human interferon alpha derivative and polyethylene glycol modified substance thereof |
05/09/2012 | CN101492498B Plant stress-resistant associated protein, encoding gene TaERECTA and uses |
05/09/2012 | CN101405391B Water deficiency condition and abscisic acid induced transcription factor gene, promoter and transgenic plant in sunflower |